Concentra Group Holdings Parent, Inc. (CON)

Concentra completed its IPO on July 26, 2024, at $23.50 per share. In August 2024, it reported a revenue increase of 2.3% and a net income of $53.1 million for Q2 2024 and declared a cash dividend. Investor sentiment improved in August 2025, leading to a 16% stock rise. In early 2025, Concentra acquired Nova Medical Centers for $265 million, expanding its network. The company reported a 15.2% revenue increase for Q2 2025, though earnings per share missed analyst expectations. Concentra is scheduled to report its Q3 2025 results on November 6, 2025.

The demand for Concentra's occupational health services generally experiences higher activity during the summer months. The company's revenue also fluctuates based on the number of business days in each calendar quarter. Concentra's business is exposed to cyclical fluctuations, as its revenue is dependent on the expansion and health of the U.S. labor force. A significant portion of its revenue is generated from workers' compensation claims, which could see declines with a reduction in the workforce. Despite this cyclical exposure, Concentra's profitability has shown resilience during past economic downturns.

Concentra Group Holdings Parent, Inc. specializes in occupational health services, including workers' compensation, employer services like screenings and physicals, and consumer health services for urgent care. It operates Concentra Telemed, Concentra Pharmacy, and Concentra Medical Compliance Administration.

Concentra has a significant national presence in the United States, operating approximately 549 to 552 stand-alone occupational health centers in 41 to 45 states and 155 to 157 onsite health clinics at employer worksites in 37 states. Its occupational health center footprint is moderately concentrated in California and Texas. Concentra serves approximately 200,000 employers and sees around 50,000 patients daily.

Concentra emphasizes its commitment to quality clinical care and its reputation for meeting the specific needs of diverse workforces, as evidenced by high patient satisfaction scores. The company highlights its role as a pioneer in workplace health and its ability to adapt to changing business environments and technology advancements. There have been no widely reported events or controversies significantly impacting Concentra Group Holdings Parent, Inc.'s brand reputation in the past year.

Concentra Group Holdings Parent, Inc. is heavily dominated by institutional owners, holding approximately 56% to 85.5% of the company's shares. Major institutional shareholders include BlackRock, Inc., T. Rowe Price Group, Inc., and The Vanguard Group, Inc.. Individual insiders own about 7.39% of the shares, while the general public holds between 4.48% and 33%.